Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CPDS Bermuda Ltd. is a specialized clinical development services subsidiary of Roivant Sciences. The company provides a centralized platform of clinical, regulatory, and operational expertise to support the development of various therapeutic candidates across Roivant's "Vant" subsidiaries. By consolidating these services, CPDS Bermuda enables Roivant to efficiently manage clinical trials and regulatory submissions for its diverse pipeline of small molecules and biologics. The entity plays a critical role in the execution of Roivant's business model of acquiring and developing de-risked drug candidates. It functions as an internal service hub, allowing individual subsidiaries to focus on specific therapeutic programs while benefiting from shared institutional knowledge and resources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CPDS Bermuda.